Table 1.

Complete case analysis of TICOPA.

TargetTight Control, n (%)Standard Care, n (%)Chi-squaredp
DAPSA remission35 (20.6)15 (8.8)8.840.004
cDAPSA remission39 (22.9)16 (9.4)11.20.001
VLDA21 (12.4)5 (2.9)9.940.002
PASDAS remission28 (16.5)13 (7.6)5.500.021
  • TICOPA: Tight Control of Psoriatic Arthritis study; DAPSA: Disease Activity Index for Psoriatic Arthritis; cDAPSA: clinical DAPSA; VLDA: very low disease activity; PsA: psoriatic arthritis; PASDAS: PsA Disease Activity Score.